The ability of Aneurinibacillus migulanus (Bacillus brevis) to produce the antibiotic gramicidin S is correlated with phenotype variation
- PMID: 17720841
- PMCID: PMC2075075
- DOI: 10.1128/AEM.00881-07
The ability of Aneurinibacillus migulanus (Bacillus brevis) to produce the antibiotic gramicidin S is correlated with phenotype variation
Abstract
Phenotype instability of bacterial strains can cause significant problems in biotechnological applications, since industrially useful properties may be lost. Here we report such degenerative dissociation for Aneurinibacillus migulanus (formerly known as Bacillus brevis) an established producer of the antimicrobial peptide gramicidin S (GS). Phenotypic variations within and between various strains maintained in different culture collections are demonstrated. The type strain, ATCC 9999, consists of six colony morphology variants, R, RC, RP, RT, SC, and SP, which were isolated and characterized as pure cultures. Correlations between colony morphology, growth, GS production, spore formation, and resistance to their own antimicrobial peptide were established in this study. We found the original R form to be the best producer, followed by RC, RP, and RT, while SC and SP yielded no GS at all. Currently available ATCC 9999(T) contains only 2% of the original R producer and is dominated by the newly described phenotypes RC and RP. No original R form is detected in the nominally equivalent strain DSM 2895(T) (=ATCC 9999(T)), which grows only as SC and SP phenotypes and has thus completely lost its value as a peptide producer. Two other strains from the same collection, DSM 5668 and DSM 5759, contain the unproductive SC variant and the GS-producing RC form, respectively. We describe the growth and maintenance conditions that stabilize certain colony phenotypes and reduce the degree of degenerative dissociation, thus providing a recommendation for how to revert the nonproducing smooth phenotypes to the valuable GS-producing rough ones.
Figures






Similar articles
-
Sporulation and spore properties of Bacillus brevis and its gramicidin S-negative mutant.J Gen Microbiol. 1983 May;129(5):1309-16. doi: 10.1099/00221287-129-5-1309. J Gen Microbiol. 1983. PMID: 6194248
-
[Lyophilization of the spores and vegetative cells of Bacillus brevis var. G-B.--producer of gramicidin S].Antibiotiki. 1983 Aug;28(8):605-8. Antibiotiki. 1983. PMID: 6195960 Russian.
-
[Sporulation and spore germination in Bacillus brevis var. G.-B. in relation to antibiotic formation].Antibiotiki. 1984 Jan;29(1):63-72. Antibiotiki. 1984. PMID: 6198956 Review. Russian. No abstract available.
-
Interactions between gramicidin S and its producer, Bacillus brevis.J Ind Microbiol. 1996 Jul;17(1):56-61. doi: 10.1007/BF01570150. J Ind Microbiol. 1996. PMID: 9004740
-
[Gramicidin S: characteristics of a producer, cultivation conditions, and interactions with a producer].Antibiot Khimioter. 2003;48(12):24-8. Antibiot Khimioter. 2003. PMID: 15176101 Review. Russian. No abstract available.
Cited by
-
Structure, toxicity and antibiotic activity of gramicidin S and derivatives.Eur J Clin Microbiol Infect Dis. 2016 May;35(5):763-9. doi: 10.1007/s10096-016-2595-y. Epub 2016 Feb 17. Eur J Clin Microbiol Infect Dis. 2016. PMID: 26886453 Free PMC article.
-
An Overview of Microorganisms Immobilized in a Gel Structure for the Production of Precursors, Antibiotics, and Valuable Products.Gels. 2024 Oct 10;10(10):646. doi: 10.3390/gels10100646. Gels. 2024. PMID: 39451299 Free PMC article. Review.
-
Insecticidal Activity of Bacteria from Larvae Breeding Site with Natural Larvae Mortality: Screening of Separated Supernatant and Pellet Fractions.Pathogens. 2020 Jun 18;9(6):486. doi: 10.3390/pathogens9060486. Pathogens. 2020. PMID: 32570965 Free PMC article.
-
Draft Genome Sequence of Aneurinibacillus migulanus NCTC 7096.Genome Announc. 2015 Apr 2;3(2):e00234-15. doi: 10.1128/genomeA.00234-15. Genome Announc. 2015. PMID: 25838489 Free PMC article.
-
Draft Genome Sequence of Aneurinibacillus sp. Strain BA2021, Isolated as a Contaminant of a Laboratory-Cultivated Predatory Myxobacterium.Microbiol Resour Announc. 2021 Apr 29;10(17):e00243-21. doi: 10.1128/MRA.00243-21. Microbiol Resour Announc. 2021. PMID: 33927039 Free PMC article.
References
-
- Afonin, S., R. W. Glaser, M. Berditchevskaia, P. Wadhwani, K.-H. Gührs, U. Möllmann, A. Perner, and A. S. Ulrich. 2003. 4-Fluoro-phenylglycine as a label for 19F-NMR structure analysis of membrane-associated peptides. Chembiochem 4:1151-1163. - PubMed
-
- Amsterdam, D. 1996. Susceptibility testing of antimicrobials in liquid media, p. 52-111. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, MD.
-
- Baumeister, W., I. Wildhaber, and H. Engelhardt. 1988. Bacterial surface proteins. Some structural, functional and evolutionary aspects. Biophys. Chem. 29:39-49. - PubMed
-
- Bourinbaiar, A. S., and C. F. Coleman. 1997. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro. Arch. Virol. 142:2225-22235. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases